Opinion: Health Reform in America—Where Are the Scientists?

Medicare for All could expand access to medical interventions—the very goal of biomedical research.

Written byRachel Madley
| 4 min read
medicare for all veterans affairs single payer healthcare insurance

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, SMARTBOY10

Over the past decade, Americans have debated the best way to fix our broken healthcare system, one that allows 35,000 Americans to die each year because they don’t have health insurance and many more to forego necessary treatment or go bankrupt paying for care. This debate has intensified in recent months due to the increasing popularity of Medicare for All, a proposal to create a publicly funded single-payer health system, and its central role in the Democratic presidential race.

First, let’s define what these terms mean: Single-payer Medicare for All would establish a public funding mechanism for healthcare that covers everyone for all medically necessary treatment, including dental, vision, and hearing care. This care would be free to everyone at the point of service, regardless of income, age, employment, or immigration status. Medicare for All changes how care is financed, but not how it’s delivered, thus ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies